Acarbose (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Acarbose" in English language version.

refsWebsite

Global rank English rank

36nih.gov

4^th place

25doi.org

2^nd place

7semanticscholar.org

11^th place

8^th place

5harvard.edu

18^th place

17^th place

2web.archive.org

1^st place

2worldcat.org

5^th place

2who.int

195^th place

302^nd place

1businessweek.com

712^th place

526^th place

1koreascience.or.kr

low place

1jst.go.jp

1,903^rd place

2,346^th place

1creativecommons.org

1,010^th place

612^th place

businessweek.com

Kresge N (21 November 2011). "China's Thirst for New Diabetes Drugs Threatens Bayer's Lead". Bloomberg Business Week. Archived from the original on 21 November 2011. Retrieved 15 April 2016.

creativecommons.org

Moreira FD, Reis CE, Gallassi AD, Moreira DC, Welker AF (9 October 2024). Dardari D (ed.). "Suppression of the postprandial hyperglycemia in patients with type 2 diabetes by a raw medicinal herb powder is weakened when consumed in ordinary hard gelatin capsules: A randomized crossover clinical trial". PLOS ONE. 19 (10): e0311501. Bibcode:2024PLoSO..1911501M. doi:10.1371/journal.pone.0311501. PMC 11463819. PMID 39383145. This article incorporates text from this source, which is available under the CC BY 4.0 license.

doi.org

Elks J, Ganellin CR, eds. (1990). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 1–. doi:10.1007/978-1-4757-2085-3. ISBN 978-1-4757-2085-3.
Jang MU, Kang HJ, Jeong CK, Kang Y, Park JE, Kim TJ (February 2018). "Functional expression and enzymatic characterization of Lactobacillus plantarum cyclomaltodextrinase catalyzing novel acarbose hydrolysis". Journal of Microbiology. 56 (2): 113–118. doi:10.1007/s12275-018-7551-3. PMID 29392561. S2CID 2660911.
Zhang W, Kim D, Philip E, Miyan Z, Barykina I, Schmidt B, et al. (April 2013). "A multinational, observational study to investigate the efficacy, safety and tolerability of acarbose as add-on or monotherapy in a range of patients: the Gluco VIP study". Clinical Drug Investigation. 33 (4): 263–274. doi:10.1007/s40261-013-0063-3. PMID 23435929. S2CID 207483590.
Zhu Q, Tong Y, Wu T, Li J, Tong N (June 2013). "Comparison of the hypoglycemic effect of acarbose monotherapy in patients with type 2 diabetes mellitus consuming an Eastern or Western diet: a systematic meta-analysis". Clinical Therapeutics. 35 (6): 880–899. doi:10.1016/j.clinthera.2013.03.020. PMID 23602502.
DiNicolantonio JJ, Bhutani J, O'Keefe JH (2015). "Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes". Open Heart. 2 (1): e000327. doi:10.1136/openhrt-2015-000327. PMC 4620230. PMID 26512331.
Moelands SV, Lucassen PL, Akkermans RP, De Grauw WJ, Van de Laar FA, et al. (Cochrane Metabolic and Endocrine Disorders Group) (December 2018). "Alpha-glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus". The Cochrane Database of Systematic Reviews. 2018 (12): CD005061. doi:10.1002/14651858.CD005061.pub3. PMC 6517235. PMID 30592787.
Smith DL, Orlandella RM, Allison DB, Norian LA (June 2021). "Diabetes medications as potential calorie restriction mimetics-a focus on the alpha-glucosidase inhibitor acarbose". GeroScience. 43 (3): 1123–1133. doi:10.1007/s11357-020-00278-x. PMC 8190416. PMID 33006707.
Hedrington MS, Davis SN (December 2019). "Considerations when using alpha-glucosidase inhibitors in the treatment of type 2 diabetes". Expert Opinion on Pharmacotherapy. 20 (18): 2229–2235. doi:10.1080/14656566.2019.1672660. PMID 31593486. S2CID 203985605.
Hoffmann J, Spengler M (December 1997). "Efficacy of 24-week monotherapy with acarbose, metformin, or placebo in dietary-treated NIDDM patients: the Essen-II Study". The American Journal of Medicine. 103 (6): 483–490. doi:10.1016/S0002-9343(97)00252-0. PMID 9428831.
Zhang L, Chen Q, Li L, Kwong JS, Jia P, Zhao P, et al. (September 2016). "Alpha-glucosidase inhibitors and hepatotoxicity in type 2 diabetes: a systematic review and meta-analysis". Scientific Reports. 6 (1): 32649. Bibcode:2016NatSR...632649Z. doi:10.1038/srep32649. PMC 5011653. PMID 27596383.
Li C, Begum A, Numao S, Park KH, Withers SG, Brayer GD (March 2005). "Acarbose rearrangement mechanism implied by the kinetic and structural analysis of human pancreatic alpha-amylase in complex with analogues and their elongated counterparts". Biochemistry. 44 (9): 3347–3357. doi:10.1021/bi048334e. PMID 15736945.
Park KH, Kim MJ, Lee HS, Han NS, Kim D, Robyt JF (December 1998). "Transglycosylation reactions of Bacillus stearothermophilus maltogenic amylase with acarbose and various acceptors". Carbohydrate Research. 313 (3–4): 235–246. doi:10.1016/S0008-6215(98)00276-6. PMID 10209866.
Kim TJ, Kim MJ, Kim BC, Kim JC, Cheong TK, Kim JW, et al. (April 1999). "Modes of action of acarbose hydrolysis and transglycosylation catalyzed by a thermostable maltogenic amylase, the gene for which was cloned from a Thermus strain". Applied and Environmental Microbiology. 65 (4): 1644–1651. Bibcode:1999ApEnM..65.1644K. doi:10.1128/AEM.65.4.1644-1651.1999. PMC 91232. PMID 10103262.
Jang MU, Kang HJ, Jeong CK, Oh GW, Lee EH, Son BS, et al. (2017). "Functional expression and enzymatic characterization of cyclomaltodextrinase from Streptococcus pyogenes". Korean Journal of Microbiology. 53 (3): 208–215. doi:10.7845/kjm.2017.7062. ISSN 0440-2413.
Baek JS, Kim HY, Abbott TP, Moon TW, Lee SB, Park CS, et al. (March 2003). "Acarviosine-simmondsin, a novel compound obtained from acarviosine-glucose and simmondsin by Thermus maltogenic amylase and its in vivo effect on food intake and hyperglycemia". Bioscience, Biotechnology, and Biochemistry. 67 (3): 532–539. doi:10.1271/bbb.67.532. PMID 12723600. S2CID 2813481.
Balaich J, Estrella M, Wu G, Jeffrey PD, Biswas A, Zhao L, et al. (December 2021). "The human microbiome encodes resistance to the antidiabetic drug acarbose". Nature. 600 (7887): 110–115. Bibcode:2021Natur.600..110B. doi:10.1038/s41586-021-04091-0. PMC 10258454. PMID 34819672. S2CID 244644880.
Park KH (2006). "Function and Tertiary- and Quaternary-structure of Cyclodextrin-hydrolyzing Enzymes (CDase), a Group of Multisubstrate Specific Enzymes Belonging to the α-Amylase Family". Journal of Applied Glycoscience. 53 (1): 35–44. doi:10.5458/jag.53.35. ISSN 1344-7882. S2CID 86894203.
Tsunoda T, Samadi A, Burade S, Mahmud T (June 2022). "Complete biosynthetic pathway to the antidiabetic drug acarbose". Nature Communications. 13 (1): 3455. Bibcode:2022NatCo..13.3455T. doi:10.1038/s41467-022-31232-4. PMC 9200736. PMID 35705566.
Bozonnet S, Jensen MT, Nielsen MM, Aghajari N, Jensen MH, Kramhøft B, et al. (October 2007). "The 'pair of sugar tongs' site on the non-catalytic domain C of barley alpha-amylase participates in substrate binding and activity". The FEBS Journal. 274 (19): 5055–5067. doi:10.1111/j.1742-4658.2007.06024.x. PMID 17803687. S2CID 25592455.
Miyazaki T, Park EY (June 2020). "Structure-function analysis of silkworm sucrose hydrolase uncovers the mechanism of substrate specificity in GH13 subfamily 17 exo-α-glucosidases". The Journal of Biological Chemistry. 295 (26): 8784–8797. doi:10.1074/jbc.RA120.013595. PMC 7324511. PMID 32381508.
Moreira FD, Reis CE, Gallassi AD, Moreira DC, Welker AF (9 October 2024). Dardari D (ed.). "Suppression of the postprandial hyperglycemia in patients with type 2 diabetes by a raw medicinal herb powder is weakened when consumed in ordinary hard gelatin capsules: A randomized crossover clinical trial". PLOS ONE. 19 (10): e0311501. Bibcode:2024PLoSO..1911501M. doi:10.1371/journal.pone.0311501. PMC 11463819. PMID 39383145. This article incorporates text from this source, which is available under the CC BY 4.0 license.
Hayward NJ, McDougall GJ, Farag S, Allwood JW, Austin C, Campbell F, et al. (December 2019). "Cinnamon Shows Antidiabetic Properties that Are Species-Specific: Effects on Enzyme Activity Inhibition and Starch Digestion". Plant Foods for Human Nutrition. 74 (4): 544–552. doi:10.1007/s11130-019-00760-8. PMC 6900266. PMID 31372918.
Yousefi M, Fateh ST, Nikbaf-Shandiz M, Gholami F, Rastgoo S, Bagher R, et al. (November 2023). "The effect of acarbose on lipid profiles in adults: a systematic review and meta-analysis of randomized clinical trials". BMC Pharmacology & Toxicology. 24 (1): 65. doi:10.1186/s40360-023-00706-6. PMC 10664642. PMID 37990256.
Harrison DE, Strong R, Allison DB, Ames BN, Astle CM, Atamna H, et al. (April 2014). "Acarbose, 17-α-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males". Aging Cell. 13 (2): 273–282. doi:10.1111/acel.12170. PMC 3954939. PMID 24245565.
Ladiges W, Liggitt D (2017). "Testing drug combinations to slow aging". Pathobiology of Aging & Age Related Diseases. 8 (1): 1407203. doi:10.1080/20010001.2017.1407203. PMC 5706479. PMID 29291036.

harvard.edu

ui.adsabs.harvard.edu

Zhang L, Chen Q, Li L, Kwong JS, Jia P, Zhao P, et al. (September 2016). "Alpha-glucosidase inhibitors and hepatotoxicity in type 2 diabetes: a systematic review and meta-analysis". Scientific Reports. 6 (1): 32649. Bibcode:2016NatSR...632649Z. doi:10.1038/srep32649. PMC 5011653. PMID 27596383.
Kim TJ, Kim MJ, Kim BC, Kim JC, Cheong TK, Kim JW, et al. (April 1999). "Modes of action of acarbose hydrolysis and transglycosylation catalyzed by a thermostable maltogenic amylase, the gene for which was cloned from a Thermus strain". Applied and Environmental Microbiology. 65 (4): 1644–1651. Bibcode:1999ApEnM..65.1644K. doi:10.1128/AEM.65.4.1644-1651.1999. PMC 91232. PMID 10103262.
Balaich J, Estrella M, Wu G, Jeffrey PD, Biswas A, Zhao L, et al. (December 2021). "The human microbiome encodes resistance to the antidiabetic drug acarbose". Nature. 600 (7887): 110–115. Bibcode:2021Natur.600..110B. doi:10.1038/s41586-021-04091-0. PMC 10258454. PMID 34819672. S2CID 244644880.
Tsunoda T, Samadi A, Burade S, Mahmud T (June 2022). "Complete biosynthetic pathway to the antidiabetic drug acarbose". Nature Communications. 13 (1): 3455. Bibcode:2022NatCo..13.3455T. doi:10.1038/s41467-022-31232-4. PMC 9200736. PMID 35705566.
Moreira FD, Reis CE, Gallassi AD, Moreira DC, Welker AF (9 October 2024). Dardari D (ed.). "Suppression of the postprandial hyperglycemia in patients with type 2 diabetes by a raw medicinal herb powder is weakened when consumed in ordinary hard gelatin capsules: A randomized crossover clinical trial". PLOS ONE. 19 (10): e0311501. Bibcode:2024PLoSO..1911501M. doi:10.1371/journal.pone.0311501. PMC 11463819. PMID 39383145. This article incorporates text from this source, which is available under the CC BY 4.0 license.

jst.go.jp

jstage.jst.go.jp

Park KH (2006). "Function and Tertiary- and Quaternary-structure of Cyclodextrin-hydrolyzing Enzymes (CDase), a Group of Multisubstrate Specific Enzymes Belonging to the α-Amylase Family". Journal of Applied Glycoscience. 53 (1): 35–44. doi:10.5458/jag.53.35. ISSN 1344-7882. S2CID 86894203.

koreascience.or.kr

Oh SW, Jang MU, Jeong CK, Kang HJ, Park JM, Kim TJ (August 2008). "Modulation of hydrolysis and transglycosylation activity of Thermus maltogenic amylase by combinatorial saturation mutagenesis". Journal of Microbiology and Biotechnology. 18 (8): 1401–1407. PMID 18756100.

nih.gov

pubmed.ncbi.nlm.nih.gov

Jang MU, Kang HJ, Jeong CK, Kang Y, Park JE, Kim TJ (February 2018). "Functional expression and enzymatic characterization of Lactobacillus plantarum cyclomaltodextrinase catalyzing novel acarbose hydrolysis". Journal of Microbiology. 56 (2): 113–118. doi:10.1007/s12275-018-7551-3. PMID 29392561. S2CID 2660911.
Zhang W, Kim D, Philip E, Miyan Z, Barykina I, Schmidt B, et al. (April 2013). "A multinational, observational study to investigate the efficacy, safety and tolerability of acarbose as add-on or monotherapy in a range of patients: the Gluco VIP study". Clinical Drug Investigation. 33 (4): 263–274. doi:10.1007/s40261-013-0063-3. PMID 23435929. S2CID 207483590.
Zhu Q, Tong Y, Wu T, Li J, Tong N (June 2013). "Comparison of the hypoglycemic effect of acarbose monotherapy in patients with type 2 diabetes mellitus consuming an Eastern or Western diet: a systematic meta-analysis". Clinical Therapeutics. 35 (6): 880–899. doi:10.1016/j.clinthera.2013.03.020. PMID 23602502.
DiNicolantonio JJ, Bhutani J, O'Keefe JH (2015). "Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes". Open Heart. 2 (1): e000327. doi:10.1136/openhrt-2015-000327. PMC 4620230. PMID 26512331.
Moelands SV, Lucassen PL, Akkermans RP, De Grauw WJ, Van de Laar FA, et al. (Cochrane Metabolic and Endocrine Disorders Group) (December 2018). "Alpha-glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus". The Cochrane Database of Systematic Reviews. 2018 (12): CD005061. doi:10.1002/14651858.CD005061.pub3. PMC 6517235. PMID 30592787.
Smith DL, Orlandella RM, Allison DB, Norian LA (June 2021). "Diabetes medications as potential calorie restriction mimetics-a focus on the alpha-glucosidase inhibitor acarbose". GeroScience. 43 (3): 1123–1133. doi:10.1007/s11357-020-00278-x. PMC 8190416. PMID 33006707.
Hedrington MS, Davis SN (December 2019). "Considerations when using alpha-glucosidase inhibitors in the treatment of type 2 diabetes". Expert Opinion on Pharmacotherapy. 20 (18): 2229–2235. doi:10.1080/14656566.2019.1672660. PMID 31593486. S2CID 203985605.
Hoffmann J, Spengler M (December 1997). "Efficacy of 24-week monotherapy with acarbose, metformin, or placebo in dietary-treated NIDDM patients: the Essen-II Study". The American Journal of Medicine. 103 (6): 483–490. doi:10.1016/S0002-9343(97)00252-0. PMID 9428831.
Zhang L, Chen Q, Li L, Kwong JS, Jia P, Zhao P, et al. (September 2016). "Alpha-glucosidase inhibitors and hepatotoxicity in type 2 diabetes: a systematic review and meta-analysis". Scientific Reports. 6 (1): 32649. Bibcode:2016NatSR...632649Z. doi:10.1038/srep32649. PMC 5011653. PMID 27596383.
Li C, Begum A, Numao S, Park KH, Withers SG, Brayer GD (March 2005). "Acarbose rearrangement mechanism implied by the kinetic and structural analysis of human pancreatic alpha-amylase in complex with analogues and their elongated counterparts". Biochemistry. 44 (9): 3347–3357. doi:10.1021/bi048334e. PMID 15736945.
Park KH, Kim MJ, Lee HS, Han NS, Kim D, Robyt JF (December 1998). "Transglycosylation reactions of Bacillus stearothermophilus maltogenic amylase with acarbose and various acceptors". Carbohydrate Research. 313 (3–4): 235–246. doi:10.1016/S0008-6215(98)00276-6. PMID 10209866.
Oh SW, Jang MU, Jeong CK, Kang HJ, Park JM, Kim TJ (August 2008). "Modulation of hydrolysis and transglycosylation activity of Thermus maltogenic amylase by combinatorial saturation mutagenesis". Journal of Microbiology and Biotechnology. 18 (8): 1401–1407. PMID 18756100.
Kim TJ, Kim MJ, Kim BC, Kim JC, Cheong TK, Kim JW, et al. (April 1999). "Modes of action of acarbose hydrolysis and transglycosylation catalyzed by a thermostable maltogenic amylase, the gene for which was cloned from a Thermus strain". Applied and Environmental Microbiology. 65 (4): 1644–1651. Bibcode:1999ApEnM..65.1644K. doi:10.1128/AEM.65.4.1644-1651.1999. PMC 91232. PMID 10103262.
Baek JS, Kim HY, Abbott TP, Moon TW, Lee SB, Park CS, et al. (March 2003). "Acarviosine-simmondsin, a novel compound obtained from acarviosine-glucose and simmondsin by Thermus maltogenic amylase and its in vivo effect on food intake and hyperglycemia". Bioscience, Biotechnology, and Biochemistry. 67 (3): 532–539. doi:10.1271/bbb.67.532. PMID 12723600. S2CID 2813481.
Balaich J, Estrella M, Wu G, Jeffrey PD, Biswas A, Zhao L, et al. (December 2021). "The human microbiome encodes resistance to the antidiabetic drug acarbose". Nature. 600 (7887): 110–115. Bibcode:2021Natur.600..110B. doi:10.1038/s41586-021-04091-0. PMC 10258454. PMID 34819672. S2CID 244644880.
Tsunoda T, Samadi A, Burade S, Mahmud T (June 2022). "Complete biosynthetic pathway to the antidiabetic drug acarbose". Nature Communications. 13 (1): 3455. Bibcode:2022NatCo..13.3455T. doi:10.1038/s41467-022-31232-4. PMC 9200736. PMID 35705566.
Bozonnet S, Jensen MT, Nielsen MM, Aghajari N, Jensen MH, Kramhøft B, et al. (October 2007). "The 'pair of sugar tongs' site on the non-catalytic domain C of barley alpha-amylase participates in substrate binding and activity". The FEBS Journal. 274 (19): 5055–5067. doi:10.1111/j.1742-4658.2007.06024.x. PMID 17803687. S2CID 25592455.
Miyazaki T, Park EY (June 2020). "Structure-function analysis of silkworm sucrose hydrolase uncovers the mechanism of substrate specificity in GH13 subfamily 17 exo-α-glucosidases". The Journal of Biological Chemistry. 295 (26): 8784–8797. doi:10.1074/jbc.RA120.013595. PMC 7324511. PMID 32381508.
Moreira FD, Reis CE, Gallassi AD, Moreira DC, Welker AF (9 October 2024). Dardari D (ed.). "Suppression of the postprandial hyperglycemia in patients with type 2 diabetes by a raw medicinal herb powder is weakened when consumed in ordinary hard gelatin capsules: A randomized crossover clinical trial". PLOS ONE. 19 (10): e0311501. Bibcode:2024PLoSO..1911501M. doi:10.1371/journal.pone.0311501. PMC 11463819. PMID 39383145. This article incorporates text from this source, which is available under the CC BY 4.0 license.
Hayward NJ, McDougall GJ, Farag S, Allwood JW, Austin C, Campbell F, et al. (December 2019). "Cinnamon Shows Antidiabetic Properties that Are Species-Specific: Effects on Enzyme Activity Inhibition and Starch Digestion". Plant Foods for Human Nutrition. 74 (4): 544–552. doi:10.1007/s11130-019-00760-8. PMC 6900266. PMID 31372918.
Yousefi M, Fateh ST, Nikbaf-Shandiz M, Gholami F, Rastgoo S, Bagher R, et al. (November 2023). "The effect of acarbose on lipid profiles in adults: a systematic review and meta-analysis of randomized clinical trials". BMC Pharmacology & Toxicology. 24 (1): 65. doi:10.1186/s40360-023-00706-6. PMC 10664642. PMID 37990256.
Harrison DE, Strong R, Allison DB, Ames BN, Astle CM, Atamna H, et al. (April 2014). "Acarbose, 17-α-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males". Aging Cell. 13 (2): 273–282. doi:10.1111/acel.12170. PMC 3954939. PMID 24245565.
Ladiges W, Liggitt D (2017). "Testing drug combinations to slow aging". Pathobiology of Aging & Age Related Diseases. 8 (1): 1407203. doi:10.1080/20010001.2017.1407203. PMC 5706479. PMID 29291036.

ncbi.nlm.nih.gov

DiNicolantonio JJ, Bhutani J, O'Keefe JH (2015). "Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes". Open Heart. 2 (1): e000327. doi:10.1136/openhrt-2015-000327. PMC 4620230. PMID 26512331.
Moelands SV, Lucassen PL, Akkermans RP, De Grauw WJ, Van de Laar FA, et al. (Cochrane Metabolic and Endocrine Disorders Group) (December 2018). "Alpha-glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus". The Cochrane Database of Systematic Reviews. 2018 (12): CD005061. doi:10.1002/14651858.CD005061.pub3. PMC 6517235. PMID 30592787.
Smith DL, Orlandella RM, Allison DB, Norian LA (June 2021). "Diabetes medications as potential calorie restriction mimetics-a focus on the alpha-glucosidase inhibitor acarbose". GeroScience. 43 (3): 1123–1133. doi:10.1007/s11357-020-00278-x. PMC 8190416. PMID 33006707.
Zhang L, Chen Q, Li L, Kwong JS, Jia P, Zhao P, et al. (September 2016). "Alpha-glucosidase inhibitors and hepatotoxicity in type 2 diabetes: a systematic review and meta-analysis". Scientific Reports. 6 (1): 32649. Bibcode:2016NatSR...632649Z. doi:10.1038/srep32649. PMC 5011653. PMID 27596383.
Kim TJ, Kim MJ, Kim BC, Kim JC, Cheong TK, Kim JW, et al. (April 1999). "Modes of action of acarbose hydrolysis and transglycosylation catalyzed by a thermostable maltogenic amylase, the gene for which was cloned from a Thermus strain". Applied and Environmental Microbiology. 65 (4): 1644–1651. Bibcode:1999ApEnM..65.1644K. doi:10.1128/AEM.65.4.1644-1651.1999. PMC 91232. PMID 10103262.
Balaich J, Estrella M, Wu G, Jeffrey PD, Biswas A, Zhao L, et al. (December 2021). "The human microbiome encodes resistance to the antidiabetic drug acarbose". Nature. 600 (7887): 110–115. Bibcode:2021Natur.600..110B. doi:10.1038/s41586-021-04091-0. PMC 10258454. PMID 34819672. S2CID 244644880.
Tsunoda T, Samadi A, Burade S, Mahmud T (June 2022). "Complete biosynthetic pathway to the antidiabetic drug acarbose". Nature Communications. 13 (1): 3455. Bibcode:2022NatCo..13.3455T. doi:10.1038/s41467-022-31232-4. PMC 9200736. PMID 35705566.
Miyazaki T, Park EY (June 2020). "Structure-function analysis of silkworm sucrose hydrolase uncovers the mechanism of substrate specificity in GH13 subfamily 17 exo-α-glucosidases". The Journal of Biological Chemistry. 295 (26): 8784–8797. doi:10.1074/jbc.RA120.013595. PMC 7324511. PMID 32381508.
Moreira FD, Reis CE, Gallassi AD, Moreira DC, Welker AF (9 October 2024). Dardari D (ed.). "Suppression of the postprandial hyperglycemia in patients with type 2 diabetes by a raw medicinal herb powder is weakened when consumed in ordinary hard gelatin capsules: A randomized crossover clinical trial". PLOS ONE. 19 (10): e0311501. Bibcode:2024PLoSO..1911501M. doi:10.1371/journal.pone.0311501. PMC 11463819. PMID 39383145. This article incorporates text from this source, which is available under the CC BY 4.0 license.
Hayward NJ, McDougall GJ, Farag S, Allwood JW, Austin C, Campbell F, et al. (December 2019). "Cinnamon Shows Antidiabetic Properties that Are Species-Specific: Effects on Enzyme Activity Inhibition and Starch Digestion". Plant Foods for Human Nutrition. 74 (4): 544–552. doi:10.1007/s11130-019-00760-8. PMC 6900266. PMID 31372918.
Yousefi M, Fateh ST, Nikbaf-Shandiz M, Gholami F, Rastgoo S, Bagher R, et al. (November 2023). "The effect of acarbose on lipid profiles in adults: a systematic review and meta-analysis of randomized clinical trials". BMC Pharmacology & Toxicology. 24 (1): 65. doi:10.1186/s40360-023-00706-6. PMC 10664642. PMID 37990256.
Harrison DE, Strong R, Allison DB, Ames BN, Astle CM, Atamna H, et al. (April 2014). "Acarbose, 17-α-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males". Aging Cell. 13 (2): 273–282. doi:10.1111/acel.12170. PMC 3954939. PMID 24245565.
Ladiges W, Liggitt D (2017). "Testing drug combinations to slow aging". Pathobiology of Aging & Age Related Diseases. 8 (1): 1407203. doi:10.1080/20010001.2017.1407203. PMC 5706479. PMID 29291036.

semanticscholar.org

api.semanticscholar.org

Jang MU, Kang HJ, Jeong CK, Kang Y, Park JE, Kim TJ (February 2018). "Functional expression and enzymatic characterization of Lactobacillus plantarum cyclomaltodextrinase catalyzing novel acarbose hydrolysis". Journal of Microbiology. 56 (2): 113–118. doi:10.1007/s12275-018-7551-3. PMID 29392561. S2CID 2660911.
Zhang W, Kim D, Philip E, Miyan Z, Barykina I, Schmidt B, et al. (April 2013). "A multinational, observational study to investigate the efficacy, safety and tolerability of acarbose as add-on or monotherapy in a range of patients: the Gluco VIP study". Clinical Drug Investigation. 33 (4): 263–274. doi:10.1007/s40261-013-0063-3. PMID 23435929. S2CID 207483590.
Hedrington MS, Davis SN (December 2019). "Considerations when using alpha-glucosidase inhibitors in the treatment of type 2 diabetes". Expert Opinion on Pharmacotherapy. 20 (18): 2229–2235. doi:10.1080/14656566.2019.1672660. PMID 31593486. S2CID 203985605.
Baek JS, Kim HY, Abbott TP, Moon TW, Lee SB, Park CS, et al. (March 2003). "Acarviosine-simmondsin, a novel compound obtained from acarviosine-glucose and simmondsin by Thermus maltogenic amylase and its in vivo effect on food intake and hyperglycemia". Bioscience, Biotechnology, and Biochemistry. 67 (3): 532–539. doi:10.1271/bbb.67.532. PMID 12723600. S2CID 2813481.
Balaich J, Estrella M, Wu G, Jeffrey PD, Biswas A, Zhao L, et al. (December 2021). "The human microbiome encodes resistance to the antidiabetic drug acarbose". Nature. 600 (7887): 110–115. Bibcode:2021Natur.600..110B. doi:10.1038/s41586-021-04091-0. PMC 10258454. PMID 34819672. S2CID 244644880.
Park KH (2006). "Function and Tertiary- and Quaternary-structure of Cyclodextrin-hydrolyzing Enzymes (CDase), a Group of Multisubstrate Specific Enzymes Belonging to the α-Amylase Family". Journal of Applied Glycoscience. 53 (1): 35–44. doi:10.5458/jag.53.35. ISSN 1344-7882. S2CID 86894203.
Bozonnet S, Jensen MT, Nielsen MM, Aghajari N, Jensen MH, Kramhøft B, et al. (October 2007). "The 'pair of sugar tongs' site on the non-catalytic domain C of barley alpha-amylase participates in substrate binding and activity". The FEBS Journal. 274 (19): 5055–5067. doi:10.1111/j.1742-4658.2007.06024.x. PMID 17803687. S2CID 25592455.

web.archive.org

Kresge N (21 November 2011). "China's Thirst for New Diabetes Drugs Threatens Bayer's Lead". Bloomberg Business Week. Archived from the original on 21 November 2011. Retrieved 15 April 2016.
"Acarbose: hepatitis: France, Spain". WHO Pharmaceuticals Newsletter. 1999. Archived from the original on 15 October 2009.

who.int

"International Nonproprietary Names for Pharmaceutical Substances. Recommended International Nonproprietary Names (Rec. INN): List 19" (PDF). World Health Organization. 1979. Retrieved 9 November 2016.

apps.who.int

"Acarbose: hepatitis: France, Spain". WHO Pharmaceuticals Newsletter. 1999. Archived from the original on 15 October 2009.

worldcat.org

search.worldcat.org

Jang MU, Kang HJ, Jeong CK, Oh GW, Lee EH, Son BS, et al. (2017). "Functional expression and enzymatic characterization of cyclomaltodextrinase from Streptococcus pyogenes". Korean Journal of Microbiology. 53 (3): 208–215. doi:10.7845/kjm.2017.7062. ISSN 0440-2413.
Park KH (2006). "Function and Tertiary- and Quaternary-structure of Cyclodextrin-hydrolyzing Enzymes (CDase), a Group of Multisubstrate Specific Enzymes Belonging to the α-Amylase Family". Journal of Applied Glycoscience. 53 (1): 35–44. doi:10.5458/jag.53.35. ISSN 1344-7882. S2CID 86894203.